HALOPERIDOL by Teva is clinical pharmacology haloperidol decanoate injection, 50 mg/ml and haloperidol decanoate injection, 100 mg/ml are the long-acting forms of haloperidol, an antipsychotic. First approved in 1987.
Drug data last refreshed 17h ago
CLINICAL PHARMACOLOGY Haloperidol decanoate injection, 50 mg/mL and haloperidol decanoate injection, 100 mg/mL are the long-acting forms of haloperidol, an antipsychotic. The mechanism of action of haloperidol for the treatment of schizophrenia is unclear. However, its efficacy could be mediated…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
IM Olanzapine Versus Haloperidol or Midazolam
Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of Schizophrenia
Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia
A Comparison Study of the Efficacy of Quetiapine and Haloperidol in Agitated Adults in Emergency Room
Pilot Study of Haloperidol to Treat Critical Illness Delirium
Worked on HALOPERIDOL at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.